Examination of the recurrence rate in the treatment of urolithiasis in patients taking beta-adrenergic receptor agonists

Examination of the recurrence rate in the treatment of urolithiasis in patients taking beta-adrenergic receptor agonists - Relationship between beta-adrenergic receptor agonists and ureteral stones

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041095

Enrollment

200

Registered

2020-07-13

Start date

2019-12-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ureteral stones

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients treated with ureteral stones at Showa University Fujigaoka Hospital

Exclusion criteria

Exclusion criteria: (1) Patients under 10 years old (2) Patients who do not get written consent (3) Patients who cannot be examined by CT (4) Patients scheduled to be treated in another hospital (5) Patients who are judged to be inappropriate by other researchers

Design outcomes

Primary

Measure	Time frame
Complete fracture rate of ureteral stones, postoperative recurrence rate, HU value	—

Countries

Japan

Contacts

Public ContactYuki Matsui

Showa University Fujigaoka Hospital Urology Department

hyperzector555@med.showa-u.ac.jp045-971-1151

Outcome results